A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma. A phase 1 clinical t…
The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial. The phase I/II trial, co-led by researchers at the Ohio …
Multiple myeloma patients are better equipped to halt progression of this blood cancer if treated with lenalidomide, or Revlimid®, following a stem cell transplant, according to a study co-authored by a physician with the Oregon Health & Science Unive…
Low dose whole body CT is nearly four times better than radiographic skeletal survey, the standard of care in the U.S., for determining the extent of disease in patients with multiple myeloma, a new study shows. The study, conducted at the University o…
An international study found that bone marrow transplants are not the best option for some young patients with acute lymphoblastic leukemia (ALL) who fail to attain clinical remission after the initial weeks of intense chemotherapy known as induction t…
A French study published Online First in The Lancet has revealed that fractionizing the dosage of the targeted anticancer drug gemtuzumab ozogamicin allows for safer delivery of the drug into patients between the ages of 50 to 70 years with acute myelo…
According to results of a randomized trial, conducted by Dr. Andreas Engert, University Hospital of Cologne, Germany, and his team, lower doses of chemotherapy can treat individuals with advanced Hodgkin’s lymphoma (a cancer affecting lymph tissue) mor…
According to a study due to be published in the March 22 issue of the New England Journal of Medicine, a set of genetic abnormalities in individuals with acute myelogenous leukemia (AML) have been identified by researchers at Memorial Sloan-Kettering C…
Researchers have identified a molecule that helps control the severity of graft-versus-host disease, a life-threatening complication for many leukemia patients who receive a bone-marrow transplant. The study, led by researchers with the Ohio State Univ…
A clinical trial published in Leukemia & Lymphoma , has shown that patients with the most common form of adult leukemia who take an aggressive drug combination can resume a normal quality of life once treatment is completed. The Leukemia & Lymphoma Re…
